http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100491647-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-286 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100491647-B1 |
| titleOfInvention | Oral dosage form of benzimidazole derivatives coated with sodium alginate and preparation method for the same |
| abstract | The present invention relates to an oral preparation comprising a core containing a benzimidazole derivative and a sodium alginate coating layer, and a preparation method thereof. The oral preparation of the benzimidazole derivative according to the present invention has excellent drug dissolution. It has the property of having excellent resistance to gastric acid and having a high storage stability, thereby providing a useful drug formulation. |
| priorityDate | 2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.